Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.2M Buy
81,911
+66,901
+446% +$16.8M 0.08% 243
2025
Q4
$4.27M Buy
15,010
+3,027
+25% +$946K 0.01% 566
2025
Q3
$3.7M Buy
11,983
+9,220
+334% +$2.89M 0.01% 570
2025
Q2
$868K Sell
2,763
-549
-17% -$158K 0.01% 903
2025
Q1
$870K Buy
3,312
+2,493
+304% +$675K 0.01% 795
2024
Q4
$214K Sell
819
-4,115
-83% -$1.04M ﹤0.01% 1176
2024
Q3
$1.15M Buy
4,934
+1,474
+43% +$303K 0.01% 501
2024
Q2
$698K Buy
3,460
+1,120
+48% +$202K 0.01% 558
2024
Q1
$401K Buy
2,340
+187
+9% +$34.9K 0.01% 700
2023
Q4
$467K Sell
2,153
-3,235
-60% -$555K 0.01% 600
2023
Q3
$859K Buy
5,388
+3,848
+250% +$862K 0.02% 431
2023
Q2
$444K Sell
1,540
-9
-0.6% -$2.73K 0.01% 575
2023
Q1
$494K Buy
1,549
+67
+5% +$19.9K 0.01% 568
2022
Q4
$436K Sell
1,482
-292
-16% -$80.5K 0.01% 550
2022
Q3
$407K Buy
1,774
+455
+34% +$114K 0.01% 583
2022
Q2
$287K Buy
+1,319
New +$300K 0.01% 618

Other funds holding PODD

IEQ Capital's PODD Position: Q1 2026 in Review

IEQ Capital increased its Insulet (PODD) stake by 446% in Q1 2026, buying an estimated $16.8M and bringing the position to 81,911 shares worth $17.2M. The position accounts for 0.08% of the portfolio, ranked #243.

IEQ Capital first reported a position in PODD in Q2 2022 and has held it in 16 quarters since. 784 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • IEQ Capital held 81,911 shares of Insulet worth $17.2M as of Q1 2026.
  • IEQ Capital bought 66,901 Insulet shares in Q1 2026, an estimated $16.8M.
  • Insulet made up 0.08% of IEQ Capital's portfolio in Q1 2026, its #243 holding.
  • IEQ Capital first reported a position in Insulet in Q2 2022 and has held it in 16 quarters since.
  • 784 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on IEQ Capital's 13F filing for Q1 2026, filed 15 May 2026.